The Private Markets Update highlights key developments emerging from private markets across Europe, the UK and the United States, exploring the cross-border issues that matter to investors and sponsors in alternative assets. ...more
10/16/2024
/ Acquisitions ,
Artificial Intelligence ,
Capital Markets ,
Cross-Border ,
EU ,
EUMR ,
Financial Conduct Authority (FCA) ,
Greenwashing ,
Healthcare ,
Investment ,
Investment Management ,
Investors ,
Life Sciences ,
Mergers ,
Private Equity ,
Regulatory Agenda ,
Regulatory Requirements ,
UK ,
United States
In this session, Ian Schwartz, Partner and Head of McDermott’s Investment Funds Practice, moderated a discussion that explored fundraising strategies and transaction structures that optimize liquidity and long-term returns...more
Hospital and Health System Innovation Centers clear the path for healthcare advancement. And in an environment upended by COVID-19, there is no better time for investment in innovation and growth of collaborative partnerships...more
11/3/2020
/ Business Development ,
Business Strategies ,
C-Suite Executives ,
Collaboration ,
Conflicts of Interest ,
Coronavirus/COVID-19 ,
Corporate Counsel ,
De-Identified Protected Health Information ,
Due Diligence ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Innovation ,
Investment Management ,
Investment Opportunities ,
Investors ,
Partnerships ,
Physicians ,
Webinars
The recent coronavirus pandemic presents significant challenges for private investment fund sponsors. Navigating these challenges requires proactively addressing risks and thoughtfully considering the following issues...more
4/1/2020
/ Coronavirus/COVID-19 ,
Corporate Governance ,
Disclosure Requirements ,
Filing Deadlines ,
Filing Requirements ,
Investment Adviser ,
Investment Company Act of 1940 ,
Investment Funds ,
Registered Investment Companies (RICs) ,
Relief Measures ,
Securities and Exchange Commission (SEC)